A bill to improve access to and appropriate utilization of valid, reliable and accurate molecular genetic tests by all populations thus helping to secure the promise of personalized medicine for all Americans.
The bill’s titles are written by its sponsor.
This is the first step in the legislative process.
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 976 (110th).
S. 3822 (109th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 109th Congress, which met from Jan 4, 2005 to Dec 9, 2006. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2016). S. 3822 — 109th Congress: Genomics and Personalized Medicine Act of 2006. Retrieved from https://www.govtrack.us/congress/bills/109/s3822
“S. 3822 — 109th Congress: Genomics and Personalized Medicine Act of 2006.” www.GovTrack.us. 2006. October 26, 2016 <https://www.govtrack.us/congress/bills/109/s3822>
|title=S. 3822 (109th)
|accessdate=October 26, 2016
|author=109th Congress (2006)
|date=August 3, 2006
|quote=Genomics and Personalized Medicine Act of 2006
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.